TELETRADER News
8/9, 5:52 PM (Source: TeleTrader)
more TeleTrader news

China's COVID vaccine to enter phase 3 of trial in Saudi Arabia

Phase 3 of China's coronavirus vaccine candidate will soon start in Saudi Arabia, the country's health ministry spokesman revealed on Sunday.

The study of the vaccine, developed by China’s CanSino Biologics, will include approximately 5,000 people, the official said.

CanSino's vaccine showed promising results during the phase 2 trial conducted in China and is also set to undergo the third phase of tests in Russia in mid-August.

Breaking the News / BU